Workflow
Huajin Capital(000532)
icon
Search documents
珠海华金资本股份有限公司 2025年第一季度报告
Zheng Quan Ri Bao· 2025-04-24 23:26
Core Viewpoint - The company emphasizes the accuracy and completeness of its quarterly report, ensuring no false records or misleading statements exist, and that all responsible parties bear legal liability for the report's content [2][3]. Financial Data - The quarterly report is not audited [3][12]. - Non-recurring gains and losses include a tax exemption amounting to 1,500.00 yuan [3]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the shareholding status of the top ten shareholders [4]. - There are no changes in the share lending situation of major shareholders compared to the previous period [4]. Significant Transactions - A rental contract was signed with an affiliate for a total amount of 11.96 million yuan for office space [4][5]. - Another rental agreement was made for a total of up to 26.5 million yuan over five years [5]. - A contract for a distributed photovoltaic power generation project was approved, with a total amount not exceeding 6.3 million yuan [5]. - The company has engaged in various leasing agreements and transactions with affiliates, including a total of 2.65 million yuan for office space and 2.37 million yuan for the overall rental of the Zhihui Bay Innovation Center [7][8]. Financial Guarantees - The company has approved a total guarantee amount of up to 500 million yuan for two subsidiaries [9]. Profit Distribution - The company has approved a profit distribution plan for the year 2024, details of which are available in a separate announcement [10]. Financial Statements - The report includes consolidated balance sheets, profit statements, and cash flow statements, all prepared in accordance with the relevant accounting standards [11][12].
华金资本(000532) - 2025 Q1 - 季度财报
2025-04-24 08:20
Financial Performance - The company's operating revenue for Q1 2025 was ¥111,594,298.23, representing a 13.73% increase compared to ¥98,119,183.49 in the same period last year[4] - Net profit attributable to shareholders decreased by 65.97% to ¥36,970,794.05 from ¥108,644,509.69 year-on-year[4] - The basic earnings per share fell by 65.96% to ¥0.1073 from ¥0.3152 in the previous year[4] - Total operating revenue for the current period reached ¥111,594,298.23, an increase of 13.4% compared to ¥98,119,183.49 in the previous period[32] - Net profit for the current period was ¥37,831,213.22, down 65.5% from ¥109,658,266.28 in the previous period[33] - Basic earnings per share decreased to ¥0.1073, compared to ¥0.3152 in the previous period, reflecting a decline of 65.9%[34] - The company reported a total comprehensive income of ¥37,783,455.61, down from ¥109,663,959.36 in the previous period, a decline of 65.6%[34] Assets and Liabilities - Total assets increased by 8.51% to ¥2,568,924,085.64 compared to ¥2,367,476,003.93 at the end of the previous year[4] - The company’s total liabilities increased to CNY 908.08 million from CNY 744.42 million, reflecting a rise of approximately 22.0%[29] - The company’s total equity as of March 31, 2025, was CNY 1.66 billion, up from CNY 1.62 billion, marking an increase of about 2.7%[30] Cash Flow - The net cash flow from operating activities decreased by 12.40% to ¥120,079,313.36 from ¥137,077,428.53 in the same period last year[14] - Net cash flow from operating activities was ¥120,079,313.36, down from ¥137,077,428.53, a decrease of 12.9%[37] - Cash and cash equivalents at the end of the period totaled ¥390,028,386.65, an increase from ¥217,943,708.46 in the previous period[38] - As of March 31, 2025, the company's cash and cash equivalents increased to CNY 393.93 million from CNY 187.69 million at the beginning of the period, representing a growth of approximately 109.0%[27] Investment and Expenses - Research and development expenses surged by 129.92% to ¥3,959,083.21, reflecting increased investment in technology to maintain market share[11] - Research and development expenses surged to ¥3,959,083.21, a significant increase of 130.0% from ¥1,721,954.56 in the previous period[33] - Investment income improved significantly, reaching ¥2,624,743.26, a 131.09% increase compared to a loss of ¥8,441,861.94 in the previous year[11] - Net cash flow from investing activities improved to ¥11,647,154.79, compared to a loss of ¥13,378,496.05 in the previous period[37] Shareholder Information - The total number of common shareholders at the end of the reporting period is 49,928[16] - Zhuhai Huafa Technology Industry Group Co., Ltd. holds 28.45% of shares, totaling 98,078,081 shares[16] - Zhuhai Water Environment Holdings Group Co., Ltd. holds 11.57% of shares, totaling 39,883,353 shares[16] - The total number of shares held by the top 10 shareholders does not include shares lent through margin trading[17] Contracts and Agreements - The total contract amount for the lease agreement with Zhuhai Huafa Technology Industry Park Management Co., Ltd. is 11.96 million RMB, with 5.28 million RMB received to date[18] - The total contract amount for the lease agreement with Zhuhai Huake Information Technology Co., Ltd. is expected to be no more than 26.5 million RMB, with 5.69 million RMB received to date[19] - The contract amount for the distributed photovoltaic power generation project with Zhuhai Huayao New Energy Construction Co., Ltd. is not to exceed 6.3 million RMB, with 297,100 RMB paid to date[19] - The total amount paid for property management services related to the new operational site in Zhuhai High-tech Zone is 7.69 million RMB[20] - The total amount received from leasing the Zhuhai Innovation Center is 23.72 million RMB to date[22] - The total amount received from leasing the unused office space in Zhuhai High-tech Zone is 5.34 million RMB[22] Financial Services - The company signed a financial service agreement with Zhuhai Huafa Group Financial Co., Ltd. for a three-year term, providing deposit, loan, and settlement services[23] - The maximum daily deposit limit with Zhuhai Huafa Group Financial Co., Ltd. is set at CNY 100 million, with an interest rate range of 0.35% to 2.75%[23] - The company’s total revenue from related transactions with Zhuhai Huafa Group Financial Co., Ltd. included a loan amount of CNY 12 million at an interest rate of 3.0% to 4.6%[23] Future Outlook - The company plans to continue investing in new product development and market expansion strategies to drive future growth[39]
华金资本:2025年第一季度净利润3697.08万元,同比下降65.97%
news flash· 2025-04-24 08:20
华金资本(000532)公告,2025年第一季度营业收入1.12亿元,同比增长13.73%。净利润3697.08万 元,同比下降65.97%。 ...
华金资本(000532) - 2024年度股东大会决议公告
2025-04-18 14:30
证券代码:000532 证券简称:华金资本 公告编号:2025-016 珠海华金资本股份有限公司 2024 年度股东大会决议公告 1、会议召集人:公司董事会 2、现场会议召开地点:横琴粤澳深度合作区华金街58号横琴国际金融中心33A层 公司会议室 3、会议方式:现场表决与网络投票相结合 4、召开时间: 现场会议召开时间为2025年4月18日(星期五)14:30起。 通过深圳证券交易所交易系统进行网络投票的时间为2025年4月18日9:15—9:25, 9:30—11:30和13:00—15:00;通过深圳证券交易所互联网投票系统投票的时间为2025 年4月18日9:15—15:00期间的任意时间。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 1、本次股东大会召开期间,无增加、否决或修改提案情况; 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 二、议案审议表决情况 本次股东大会采用现场记名投票与网络投票相结合的方式逐项审议并通过了相 关议案,形成决议如下: 1、通过了《关于〈2024 年度董事会工作报告〉的议案》 ...
华金资本(000532) - 北京德恒(珠海)律师事务所关于珠海华金资本股份有限公司2024年度股东大会的法律意见书
2025-04-18 14:24
北京德恒(珠海)律师事务所 关于珠海华金资本股份有限公司 2024年度股东大会的 法律意见书 北京德恒(珠海)律师事务所 广东省珠海市香洲区凤凰北路2099号安广世纪大厦19楼 电话: 0756-3263939 传真: 0756-3293638 邮编: 519000 北京德恒(珠海)律师事务所 北京德恒(珠海)律师事务所 关于珠海华金资本股份有限公司 2024年度股东大会的 法律意见书 致:珠海华金资本股份有限公司 北京德恒(珠海)律师事务所(以下简称"本所")受珠海华金资本股份 有限公司(以下简称"华金资本"或"公司")委托,指派本所刘亚晶律师和 会家燕律师出席华金资本2024年度股东大会(以下简称"本次股东大会"), 对本次股东大会的合法性进行见证,并出具本法律意见。 本法律意见根据《中华人民共和国公司法》(以下简称"《公司法》")、 《中华人民共和国证券法》〈以下简称"《证券法》")、《珠海华金资本股份 有限公司章程》(以下简称"《公司章程》")、《公司股东大会议事规则》(以 下简称"《股东大会议事规则》")等有关法律、法规和规范性文件而出具。 为出具本法律意见,本所律师审查了华金资本本次股东大会的有关 ...
多元金融板块走高 九鼎投资涨停
news flash· 2025-04-14 05:57
暗盘资金一眼洞悉庄家意图>> 多元金融板块走高,九鼎投资(600053)涨停,海德股份(000567)此前封板,鲁信创投(600783)、 华金资本(000532)、香溢融通(600830)、弘业期货(001236)、翠微股份(603123)等跟涨。 ...
珠海华金资本股份有限公司关于控股股东上层股权结构拟发生变动的提示性公告
Group 1 - The core point of the announcement is that the equity structure of the controlling shareholder of Zhuhai Huajin Capital Co., Ltd. is set to change, but the controlling shareholder and actual controller remain the same [2][3] - The restructuring involves the establishment of Zhuhai Technology Industry Group Co., Ltd., with Zhuhai Huafa Group Co., Ltd. and Zhuhai Gree Group Co., Ltd. collaborating to inject certain equity and assets into the new entity [2] - After the restructuring, Huafa Technology will continue to be the controlling shareholder of the company, and the Zhuhai State-owned Assets Supervision and Administration Commission will remain the actual controller [2][3] Group 2 - The impact of the restructuring on the company is minimal, as the controlling shareholder and actual controller have not changed, ensuring no substantial effect on the company's operations and production activities [3] - The company will continue to monitor the progress of the restructuring and will comply with legal disclosure obligations [4]
4月14日上市公司重要公告集锦:中国人保一季度净利预增30%—50%
Zheng Quan Ri Bao· 2025-04-13 13:43
Group 1: Company Announcements - China Pacific Insurance (China Life) expects a net profit increase of 30% to 50% for Q1 2025, projecting a profit range of 11.652 billion to 13.445 billion yuan [2] - New Lai Fu plans to acquire 100% equity of Guangzhou Jin Nan Magnetic Materials, with trading suspension starting from April 14, 2025, due to significant asset restructuring [3] - Jiangling Motors intends to repurchase A-shares with a total fund of no less than 1.5 billion and no more than 2 billion yuan, at a price not exceeding 22.00 yuan per share [4] - Guanghua Technology anticipates a net profit increase of 479.25% to 637.23% for Q1 2025, estimating a profit range of 22 million to 28 million yuan [7] - Starhua New Materials reported a net profit of 148 million yuan for 2024, with a year-on-year increase of 51.93%, and plans to distribute a cash dividend of 8 yuan per 10 shares [10] Group 2: Clinical Trial Approvals - Heng Rui Pharmaceutical received approval for clinical trials of HRS-9190, a new drug for anesthesia, and SHR-3792, an innovative anti-tumor candidate, with no similar drugs approved in the market [1]
光库科技、华金资本控股股东“上层重构” 华发集团与格力集团共同组建珠海科技集团
珠海推进国企专业化整合,光库科技(300620)、华金资本(000532)控股股东珠海华发科技产业集团有限 公司(下称"华发科技")上层股权结构拟发生变动。 据光库科技、华金资本4月13日晚公告,两家公司实际控制人为珠海市国资委下发《关于组建珠海科技 产业集团有限公司的通知》,根据《珠海市2025年市属国有企业专业化整合方案》要求,珠海华发集团 有限公司(下称"华发集团")与珠海格力集团有限公司将共同组建珠海科技产业集团有限公司(暂定名,下 称"珠海科技集团"),华发集团将所持有的部分股权和资产(含华发科技股权)对珠海科技集团进行注资。 本次组建完成后,珠海科技集团将成为华发科技的股东。华发科技仍为光库科技、华金资本的控股股 东,珠海市国资委仍为两家上市公司实际控制人。 两家上市公司均表示,本次专业化整合系华发科技的股权结构变化。整合后,公司控股股东和实际控制 人均未发生变化,不会对公司的经营和生产活动产生实质性影响。 在此前4月11日,格力集团旗下格力金投的控股公司航宇微(300053)、阳普医疗(300030)等也公告,收到 控股股东格力金投的《关于股权结构拟变动调整的通知》,并发布控股股东上层股权结构拟 ...
同比最高增超600%!芯片概念股发布一季报预告|盘后公告集锦
Xin Lang Cai Jing· 2025-04-13 11:26
Group 1: Company Performance - Guanghua Technology expects a net profit growth of 479% to 637% year-on-year for Q1 2025, with an estimated profit of 22 million to 28 million yuan, driven by business expansion in specialized chemicals and cost reduction measures [1] - China Pacific Insurance anticipates a net profit increase of 30% to 50% year-on-year for Q1 2025, projecting a profit of 11.652 billion to 13.445 billion yuan, attributed to improved business quality and significant investment performance [2] - Zhenyu Technology forecasts a net profit growth of 31.54% to 42.97% year-on-year for Q1 2025, estimating a profit of 69 million to 75 million yuan, supported by increased sales orders and enhanced production automation [7] - Chuangjiang New Materials expects a net profit increase of 26.74% to 46.24% year-on-year for Q1 2025, with an estimated profit of 130 million to 150 million yuan, driven by stable growth in production and sales [8] Group 2: Corporate Actions - Xinlaifu plans to acquire 100% equity of Guangzhou Jinnan Magnetic Materials, leading to a significant asset restructuring, with trading suspended from April 14, 2025 [2] - Jiangling Motors intends to repurchase A-shares worth 150 million to 200 million yuan for employee stock ownership plans or equity incentives [5] - Yingfeite plans to repurchase shares worth 50 million to 100 million yuan for employee stock ownership or equity incentive plans [6] - Guanghua Technology's major shareholder is undergoing a change in its upper equity structure, but the actual controller remains the Zhuhai State-owned Assets Supervision and Administration Commission [4] Group 3: Regulatory Approvals - Hengrui Medicine received approval for clinical trials of its new drug HRS-9190, which is intended for use during anesthesia induction and maintenance [9]